Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangxi Jinji Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the development and manufacture of Traditional Chinese Medicine (TCM) and modern pharmaceuticals, with a core focus on women's health. The company is best known for its flagship "Jinji" brand series, particularly the Jinji Granules (Jinji Keli), which are widely recognized in China for treating gynecological inflammatory diseases. As a key subsidiary of the publicly traded Zhongheng Group, it operates large-scale, GMP-certified manufacturing facilities for various dosage forms including granules, tablets, and capsules. Beyond its TCM portfolio, the company also produces generic small molecule antibiotics and over-the-counter respiratory medications. Its products are distributed extensively across the Chinese domestic market, maintaining a strong reputation in the gynecological therapeutic area.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangxi Jinji Pharmaceutical.